Yostra Labs

Yostra Labs Private Limited is a healthcare technology firm established in 2014, focusing on the significant and often neglected market of diabetic complications, particularly in cost-sensitive developing markets. The Bengaluru-based company was founded by an interdisciplinary team of clinicians, designers, and engineers: Vinayak Nandalike, Ram Mohan Rao, Dr. Sanjay Sharma, and Dr. Maruthy K N. This collaborative foundation of medical and technical expertise addresses the challenges of diabetic peripheral neuropathy (nerve damage) and chronic wounds like diabetic foot ulcers, which have a higher mortality rate than many cancers.

The company operates on a business-to-business (B2B) model, selling its medical devices directly to healthcare providers such as clinics, hospitals (both private and government), and diagnostic centers. Yostra Labs generates revenue through the sale of its hardware products. By August 2022, its devices had already been used to screen over 40,000 patients across India. A significant milestone was achieved in August 2022 when the company secured INR 4 crore in a seed funding round led by the Indian Angel Network (IAN) and joined by Villgro Innovations Foundation and the Centre for Cellular and Molecular Platforms. This capital was earmarked for expanding its sales and marketing teams, commercializing its product portfolio, and scaling production.

Yostra's flagship product is the NEURO TOUCH, a portable, point-of-care screening device for diabetic peripheral neuropathy. This device consolidates multiple tests—including monofilament, vibration perception, hot and cold perception, and infrared skin thermometry—into a single, handheld, battery-operated unit. It offers a significant advantage over traditional, bulky equipment by enabling early and comprehensive screening. The device is Bluetooth-enabled and connects to a smartphone app, which uses AI to generate cloud-based reports, allowing for real-time analysis, storage, and remote printing of test results. Another key product is VELOX Care, an advanced wound care solution that utilizes topical warm oxygen therapy to accelerate the healing of chronic wounds such as diabetic foot ulcers. The company also offers the NEURO KIT and has developed other devices like Kadam and Sparsh for similar diagnostic and therapeutic purposes.

Keywords: diabetic neuropathy, medical devices, peripheral neuropathy, wound care, healthcare technology, diabetes management, diabetic foot ulcer, point-of-care diagnostics, NEURO TOUCH, VELOX Care, medtech, affordable healthcare, chronic disease management, portable medical devices, digital health, AI in healthcare, remote patient monitoring, India healthcare, seed funding, Bangalore startup